Ambev SA

Ambev SA (ABEV) Stock Analysis

$3.250

-0.040 (-1.22%)At close

Loading chart…
High
3.300
Open
3.300
VWAP
3.26
Volume
21.68M
Mkt Cap
32.92B
Low
3.220
Amount
70.62M
EV/EBITDA, TTM
1.26

Ambev SA, formerly Inbev Participacoes Societarias SA, is a Brazil-based company engaged in the brewing sector. The Company produces, distributes and sells beer, carbonated soft drinks (CSDs) and other non-alcoholic and non-carbonated (NANC) beverages across the Americas. The Company's activities are divided into three segments: Latin America North, including sell of beer, CSD and NANC drinks in Brazil, as well as operations in the Dominican Republic, Saint Vincent, Antigua, Dominica, Cuba, Guatemala, El Salvador, Honduras, Nicaragua, Barbados and Panama; Latin America South, distributing products in Argentina, Bolivia, Paraguay, Uruguay, Chile; and Canada, represented by Labatt’s operations, which comprises sales in Canada and some exports to the U.S. market. The Company markets products under various brand names, such as Adriatica, Brahma, Leffe, Budweiser, Corona, PepsiCo and Lipton. It is a subsidiary of Interbrew International BV.

AI analysis of Ambev SA (ABEV)

Buy

Ambev SA is a good buy right now due to its current price of $3.29, which is below the analyst price target of $3.30 set by BofA, indicating limited downside. Additionally, the stock has shown a strong year-to-date change of +33.20% and a 1-year change of +44.93%, reflecting solid performance. The RSI is at 78.487, suggesting it is in overbought territory, but the strong earnings growth and market sentiment following the recent election results in Brazil provide a positive outlook. The main risk is the downgrade by BofA, which cites muted earnings momentum and tough cost outlooks for 2027, indicating potential challenges ahead.

Valuation Metrics

The current forward P/E ratio for Ambev SA (ABEV) is 13.23, compared to its 5-year average forward P/E of 15.01.

Forward P/E

Fair
5Y Average P/E
15.01
Current P/E
13.23
Overvalued
18.05
Undervalued
11.96

Forward EV/EBITDA

Undervalued
5Y Average EV/EBITDA
6.58
Current EV/EBITDA
1.26
Overvalued
9.30
Undervalued
3.87

Forward P/S

Strongly Undervalued
5Y Average P/S
2.19
Current P/S
0.53
Overvalued
3.00
Undervalued
1.37

Alphio AI Price Scenarios for ABEV

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%ABEV

$2.86

Scenario price

B

Base

Base · 50%ABEV

$2.53

Scenario price

B

Bear

Bear · 25%ABEV

$2.02

Scenario price

Whales holding ABEV

P

PPLA Participations Ltd.

+ HoldingABEV

+20.31%

3M Return

S

Seafarer Capital Partners, LLC

+ HoldingABEV

+11.02%

3M Return

I

Itaú Unibanco Holding S.A.

+ HoldingABEV

+10.05%

3M Return

C

Caixa Econômica Federal

+ HoldingABEV

+7.78%

3M Return

G

GQG Partners, LLC

+ HoldingABEV

+6.74%

3M Return

R

RWC Partners Limited

+ HoldingABEV

+5.94%

3M Return

ABEV FAQ — answered by Alphio AI

Ambev SA, formerly Inbev Participacoes Societarias SA, is a Brazil-based company engaged in the brewing sector. The Company produces, distributes and sells beer, carbonated soft drinks (CSDs) and other non-alcoholic and non-carbonated (NANC) beverages across the Americas. The Company's activities are divided into three segments: Latin America North, including sell of beer, CSD and NANC drinks in Brazil, as well as operations in the Dominican Republic, Saint Vincent, Antigua, Dominica, Cuba, Guatemala, El Salvador, Honduras, Nicaragua, Barbados and Panama; Latin America South, distributing products in Argentina, Bolivia, Paraguay, Uruguay, Chile; and Canada, represented by Labatt’s operations, which comprises sales in Canada and some exports to the U.S. market. The Company markets products under various brand names, such as Adriatica, Brahma, Leffe, Budweiser, Corona, PepsiCo and Lipton. It is a subsidiary of Interbrew International BV. It operates in the Consumer Non-Cyclicals sector.

Ambev SA is a good buy right now due to its current price of $3.29, which is below the analyst price target of $3.30 set by BofA, indicating limited downside. Additionally, the stock has shown a strong year-to-date change of +33.20% and a 1-year change of +44.93%, reflecting solid performance. The RSI is at 78.487, suggesting it is in overbought territory, but the strong earnings growth and market sentiment following the recent election results in Brazil provide a positive outlook. The main risk is the downgrade by BofA, which cites muted earnings momentum and tough cost outlooks for 2027, indicating potential challenges ahead.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading